News

The results of the study were presented during the ongoing ESHRE (European Society of Human Reproduction and Embryology) conference in Rome by Matts Wikland. Vitrolife said that the

Furiex Pharma has developed Dapoxetine in collaboration with Alza Corporation and its affiliates. The patent include claims directed to dosing Dapoxetine on an as-needed basis, capturing the advantage

Sanofi-aventis and JDRF said that their partnership is expected to focus on therapeutics such as immune therapies and beta cell regeneration. As per the terms of the partnership,

Gen-Probe’s Aptima Trichomonas assay utilises the same nucleic acid amplification technologies as the Aptima Combo 2 assay for chlamydia and gonorrhea. The studies have shown that Gen-Probe’s Transcription-Mediated

Burkert claimed that the hygienic design and glass-free construction of the 8201pH sensor mean that the unit is particularly suitable for use in high- end hygienic processes. Additionally,

Omnaris HFA is an aerosol nasal formulation of ciclesonide, for the treatment of seasonal allergic rhinitis (SAR) in adult and adolescent patients. Ciclesonide is the active ingredient in

Sanofi-aventis is initially expected to produce oral antidiabetic and cardiovascular products in the new plant which is to be build in 35,000 square meter land. The agreement was

Cubist said that CXA-201, a combined product of CXA-101 and the beta-lactamase inhibitor tazobactam, is being developed by the company as a first-line intravenous therapy for the treatment

Thermo Fisher Scientific said that the new library has been computationally engineered to build on the customer-driven features of the original Maybridge Ro3 Library, such as ‘Rule of